CN Patent

CN105517540B — 两种抗病毒化合物的复方制剂

Assigned to Gilead Sciences Inc · Expires 2019-08-23 · 7y expired

What this patent protects

公开了包含具有下式的化合物I和有效量的索非布韦的药物组合物，其中索非布韦基本上是晶体。还公开了所述药物组合物的使用方法。

USPTO Abstract

公开了包含具有下式的化合物I和有效量的索非布韦的药物组合物，其中索非布韦基本上是晶体。还公开了所述药物组合物的使用方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN105517540B
Jurisdiction: CN
Classification: —
Expires: 2019-08-23
Drug substance claim: No
Drug product claim: No
Assignee: Gilead Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.